RAIRIN Trademark

Trademark Overview

On Monday, June 23, 2014, a trademark application was filed for RAIRIN with the United States Patent and Trademark Office. The USPTO has given the RAIRIN trademark a serial number of 86317543. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 25, 2017. This trademark is owned by Glaxo Group Limited. The RAIRIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
rairin

General Information

Serial Number86317543
Word MarkRAIRIN
Filing DateMonday, June 23, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 25, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 30, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe English translation of "RAIRIN" in the mark is "advent", "attendance", "coming", "presence", or "visit".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 30, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, September 25, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 25, 2017ABANDONMENT - NO USE STATEMENT FILED
Saturday, February 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 23, 2017EXTENSION 4 GRANTED
Thursday, February 23, 2017EXTENSION 4 FILED
Thursday, February 23, 2017TEAS EXTENSION RECEIVED
Saturday, August 6, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 5, 2016EXTENSION 3 GRANTED
Thursday, July 28, 2016EXTENSION 3 FILED
Thursday, July 28, 2016TEAS EXTENSION RECEIVED
Friday, March 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 17, 2016EXTENSION 2 GRANTED
Thursday, February 11, 2016EXTENSION 2 FILED
Monday, March 14, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 11, 2016TEAS EXTENSION RECEIVED
Thursday, July 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 30, 2015EXTENSION 1 GRANTED
Tuesday, June 30, 2015EXTENSION 1 FILED
Tuesday, June 30, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 24, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 30, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 30, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 10, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 21, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 18, 2014ASSIGNED TO LIE
Friday, October 31, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 30, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 29, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 29, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, October 4, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, October 4, 2014NON-FINAL ACTION E-MAILED
Saturday, October 4, 2014NON-FINAL ACTION WRITTEN
Monday, September 29, 2014ASSIGNED TO EXAMINER
Monday, June 30, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 26, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

rairin pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological